o)roNrtrot

oNo)oror@
ooo,o)ocn

q oqcln-q (.)ec.,l-@so9(')q
(O-(j(.)@6)Nn@
o oNo)o,o,@
ooorororo, Nlr)(ONC\l--rr
o
q oo<)ooo oooooo
oooooo o
oooooo
oo<)ooo oooooo
(J oooooo oooooo o
o oooooo
o

-c lr,@(ortor,
(.)O.o@-O \raooraroo(o@t
..16-6
gt o)or(oN(o !rct(o(frcD@(ort
'6 rrtO-N< 66NCDrr,-O:rd'
@co@@@@ c{tNoooo)o)@

roaoot@ao (o!o@N(Orlr)C\r(O o
oo(o(o-ro, (Ol,)C!@tr:rct@
to @o,(r)@!r,
(f)@@('C.lt
tr)o)@-@@
(ot-c!t--Fq)(or(o
ar a! ol lr)r
d@-Nsco@6F
I F- {r- oi
I {roN(')(\tN
o)o)o,oo)o) c{$o-N-OOO

E
o
q (\t F g-cDor(')o) @@@@r.-@@@o,
N t @@'!!oLqlr) (o (o (, ra) ra, l.) ra, (, (,
CJ
o tl<_$s9 gsiii+s{t
.c N \
gE o
z . <) ooo
_Eo oo o o oo o o o o oooo o o
o o o o o o o o o o o o o o o o o o o
I a,t
ol
N
o
tt c
o E
rNNC!NNN e ('i rO (O l.- @ r C\,1 ('rN r
S q 5---
E EI
-;---
9
(I]
z P or
t lr)
o,,r,
ro o
(o
o
r
N
o)
o
r"l
-r..
F-
F .r, N @ .q cD s
c! (t c) s v ra)
o
o
(o F F- t-r
o e - (\ N
@
(D
i: - c.r i .rj rb
or rjo o r- <.1 (e \r,.,F- @o,or (r) N
o = ;(o \t 6 o F
\l N d) O N (.) t !r, o - o o o O
N t
F
D
q)
o
0)
t tl r'- r- x @ @
"o
@ @ o o o o, o o o o
(L N N N N N N C! N CI N N C{ N N GI N C.T N N N c)
6 o ., N N C\r N N N N C! C! C! N N C{ N N N N N N N -c
o .i00000000000000000000
E.
(!
()
.c
o e< 4 4 4 4 4 4 4 ('4 4ra) ra)
Q \O rO to rO lr) (O rO lr)
44
4 lr)4 (r)
4 (r) 44
(r) lr) 44
lr) rO l.r) 4 ra)
< o o o o oo o <) oo o o o o o oo o o o
.g =
c o
E9
:E
E,
o-
->E
8f.o o
E€ E
(!
tt o c
=
6o,E 5 rCrl(Y)tlr)(O
ooooooo
9u) ttlttt
ccccccc I

^r
+oq tr .9.9.9.e99 9
>OE q,
fl:rllrl
xE 6S
(\* o.
66E6Eo
c)66466 o
A
>o: o
do l,i; 6 ====== alol-.-.-. =
€
oo
.> 1-. -o€PP€P
lfSll:r'='====f
E9e oooaoo frd6o*aaaa.*
'i-i-i t/>

(D E EE (I,, E
dl E
ol
<1 c\r ot
o l. E 0) d) (l)r a-_r -_r a -_r --r -_r ra rr
a -_r a.a.a r Eo r
NE CaC o o (! o o o o o < o
6 tb 6C;lth th
N -E th llg_Q_Q
EEe''- I ^9 6 d > > > > (o 6 6 6 6 6
= =
!- O aNt-
: ELO O o
2 -j
>ooL N (,) S rO (O F @ O) O F C{ (') $ rO (O F- @ o) O -
I N- .. o oooooooo--Na.r t)
otrrrrrrrtttttttttttt
Gt
=E.h
rL:}E E O@
NF
(,
.E
o o o oo o o oo g o o
,E,E,q,E,E,E,g,E E
o o o Q oo
E g g.g.g.E g g o
q)
9 E :
F(!O; EEEEEEEEEEEEEEEEEEEE
<trJ>
'\ =/1 0
<o;
cro (t,
(n(!(!(s(tr(E(E(6lE(E(D(!(E(0(tr(!(o(!(E(E

= =
u)z 9or
oq!
: 555>5'55>55>>>>55>5>
tttrtttttttttttttttt
o-(/,d> E(\t o N
N
N N 6I N N
N C! C.l 6/ C.l N a.l N N
oooooooooooooooooooo
N GI N N N
(\l CTI C{ N
N N
N
c..| N
C! N
c! N
N
N
N
N
C{
c! o
-rroaii l:> o- d, N N N N N N N N N N GI N N N C{.! N N N N
9=53 ro
9z E lr) l.) (.) (.) ro lr) |J) (.) r.) lr) ro lr, ro o lr,) (o !o ll) (r) rr)
t 90= I r.-
a;
E zoo oooooooooooooooooo

oa
.E iio
Ui rJ i?
ci5
o !E - N (Y) !l rO (O N @ O) O - N a) t r.) (O F- @ O) I
FFFFFFCTI

c0
<.}-6
o E 3< ;?
ol o
oo
E E -g=
lriEX E2
0)l!
E
o orc!(otl.)(or-@o)o
(E
E
<OoJ =() o t- -FFF-Fa!
 E
q
o
.E
E J
g
I
N
(\t
o
N
F
9
m
i
m
o E
tU
0)

(Io o
c)
o -c
E o
(L
(.)
.=
Fe
8=i
z Eii
-(l)=

B -e'.E
q 9@
+(t.)o
ioE oo
x(S
cN*
>\o:
J C\t,:_r

S98
NN t-
t-
firBx
t- 9(\lN
ao
o
: CLO O
>ooL (,) :
o
-, E .), o)
u bEE
F (!o 6
rl) 3o eu J
cD
c o<
.E
<F), >
'= -9---.: c
>EOo l!
: EF--9(,
= =t!.tz t9 (o o-
o-(,,d o E
rEr.i; = o-
=3q
(r) o\ d)
9553 *o,
^L
-3i
kgo> id
E
iD !Aul
G
fr.E ii E EsH su t
d\) o)
Eor-arP co
{C;-9g<
o= o 3o 35
X o(, o oo
o<)
I E
o)
o. = o-,. oY", oo
o(6.g;
l:(oX
E
o
=
E urL.n
o oE o Cr (!
<ooi o OtrO'dO asuodssU c
AURIGA RESEARCH PRIVATE LIMITED
Quantify Sample Report MassLynx V4.2 SCN1001
Datasetr D:\ARBLEQLCMS-002\2022\NOV_2022\Development\Vitamine. PRO\PeakDB\071 12022-Vitam ine.qld
Last Altered: Monday, November 07,2022 09:18:14 lndia Standard Time

Method: D:\Arbleqlcms-002\2022\Nov_2022\DevelopmentWitamine.PRO\MethOB\VlTAMlNE.mdb 02 Nov 202210:11 :0'l

Calibration:
O7 Nov 2022 09:18:14

Name: 05112022_Vitam ine-02, Date:05-Nov-2022,Time:17:31:59, lD: Blank, Description: , Vial: 'l:A,1

Provitamine D3
Blank MRM of 4 channels.AP+
3673>1592
165 252 6 52 4 942e+OO3
707 51

min

Slank MRM of 4 channels.AP+

3673> 145 1
5 788e+003
6
164 478 979
min
2.00 400 6.00 800

RT Area 1 Conc
1 1 Provrtamine D3 00

Analysed By
@--1 Checked By: rr\,\,,./
Ll l',,Ia't r-
AURIGA RESEARCH PRIVATE LIMITED
Quantify Sample Report MassLynx V4.2 SCN1001
Dataset: D:\ARELEQLCM5-002\2022\NOV_2022\Developmentvitamine. PRO\PeakDB\071 12022_Vitam ine.qld
Last Altered: Monday, November 07 , 2022 09:18. 14 lndia Standard Time

Name: 051 12022_Vitamine_03, Date: 05-Nov-2022,Time: 17:42:59,|D: System Suitibility Solution_O1, Description: , Vial: 1:A,2

Provitamine O3
MRM of 4 channels,AP+
367 3 > '159.2
A.a72e+004

'/o 250
mtn

MRM ol4 channels,AP+

3673> t45 1

I 480e+004
90-:
v.1 24A
-1 mrn
200 400 600 800

,|
1 Provitamrne D3 4 64 9453.805 9552 917 0990 10 100s

\l \
u.--
Analysed By: @'-tu1102 L Checked By: o
$2 f
AURIGA RESEARCH PRIVATE LIMITED
Quantify Sample Report Masslynx V4.2 SCN1001
Dataset: D:\ARBLEQLCMS-002\2022\NOV_2022\Development\Vitamine. PRO\PeakDB\l7112022_Vitamine qld
Last Altered: Monday, November 07,2022 09:18114 lndia Standard Tame

Name: 05112022_Vitamine_04, Date:05-Nov-2022,Tirne:17:54:05, lD: System Suitibility Solution_o2, Description:, Vial:1:A,2

Provitamine D3
MRM of 4 channels.AP+
367.3 > 159.2
8 758e+004

o/a
247
-1 min

MRM of 4 channels,AP+
367 3 > 145.1
A.074e+OO4

o/o
247
-10 mrn
200 400 600 800

1 1 Provrtamrne D3 4 61 9596 938 9022 69r 1.064 1.0 102

Analysed By: Checked By: )-l \' \q

Cq ltt\t ot y
AURIGA RESEARCH PRIVATE LIMITED
Quantify Sample Report MassLynx V4.2 SCN1 O0l
Dataset: D.\ARBLEQLCM5-002\2022\NOV_2022\Development\Vitamine.PRO\PeakDB\071 12022_Vitam ine. qld
Last Altered: Monday, November 07,2022 09 18 14 tndia Standard Time

Name: 05112022-Vitamine-05, Date: 05-Nov-2022, Time: 18:05:05, lD: System Suitibility Solution_o3, Description: , Vial: 1:A,2

Provitamine D3
l\4RM of 4 channels.AP+
3673>1592
8 334e+004

o/o

-1 mrn

MRM of 4 channels,AP+
367 3 > 145.1
7 884e+004
o/a
247
min
200 400 600 800

1 1 (A... Conc
1 1 Provitamrne 03 4.59 9288 560 8808.280 1 054 10 99

Analysed By: q-r Checked By o

lr \k

selrr\ebL2
AURIGA RESEARCH PRIVATE LIMITED
Quantify Sample Report MassLynx V4.2 SCN1001
Dataset: D:fARBLEQLCMS-002\2022\NOV_2022\Development\Vitamine. PRO\PeakDB\07112022_Vitamine.qld
Last Altered: Monday, November 07, 2022 09.18.14 lndia Standard Time

Name: 051 12022_Vitam ine_06, Date: 05-Nov-2022,Time: '18:'16:09, lD: System Suitibility Solution-o4, Oescription: , Vial: 1:A,2

Provitamine D3
MRM of 4 channels,AP+
367 3 > 159.2
a 622e+OO4
90
o/a
247
-1 mrn

MRM of 4 channels.AP+
367 3 > 145.1
8.287e+004
o/o
247
mrn
200 400 6.00 8.00

1 1 Provitamine D3 4.59 9313 864 9077 121 1026 1 0 99

r\vu-----
Analysed By Checked By.
lrrlQ.oz 2-
AURIGA RESEARCH PRIVATE LIMITED
Quantify Sample Report MassLynx V4.2 SCN1001
Dataset: D:\ARBLEQLCM5-002\2022\NOV_2022\Development\Vitamine. PRO\PeakDB\071 12022_Vitam ine.qld
Last Altered: Monday, Novembet07,2022 09:18:14 lndia Standard Time

Name: 051 12022_Vitamine_07, Date: 05-Nov-2022, Time: 18:27:13,1D: System Suitibility Solution-os, Description: , Vial: 1:A,2

Provitamine D3
MRM of 4 channels.AP+
3673>1592
I 537e+004

o/a
247
mrn

MRM of 4 channels,AP+
3673> 145 1
8.164e+004
o/o
244
mln
200 400 600 800

Name
1 1 Provilamine D3 4 59 9282 438 8942 993 r 038 1.0 99.'l

Analysed By qn c.? (\r It o'L t-

Checked By: o
lr \r
AURIGA RESEARCH PRIVATE LIMITED
Quantify Sample Report MassLynx V4.2 SCN1001
Dataset: D;\ARBLEQLCM5-002\2022\NOV_2022\Development\Vitamine. PRO\PeakDB\071 12022-Vatamine.qld
Last Alteredl Monday. November 07, 2022 09.18:14 lndia Standard Time

Name: 051 12022_Vitamine_08, Date: O5-Nov-2022, Time: 18:38:17, lO: System Suitibility Solution-06, Oescription: , Vial: 1:A,2

Provitamine D3
MRM of 4 channels,AP+
367 3 > 159.2
8 784e+004
90:
a/a
247
mrn

irRM of 4 channeis,AP+
367 3 > 145 1

8.233e+004
o/o
248
-1 min
200 400 600 800

1 1 Provrtamine D3 4.59 9264.398 9108.182 1017 1.0 98.9

1.1
,' \€
Analysed Byl
@R,,,, Checked By:
AURIGA RESEARCH PRIVATE LIMITED
Quantify Sample Report Masslynx V4.2 SCNIOOI
Dataset: D:\ARBLEQLCMS-002\2022\NOV_2022\Developmentvitamine.PRO\PeakDB\071 12022_Vitamine qtd
Last Altered: Monday, Novem b er 07 , 2022 09: 1E: 14 tndia Standard Time

Name: 05112022_Vitamine_09, Date: 05-Nov-2022, Timei 11i49i21,lO: Blank, Description: , Vial: 1:A,l

Provitamine D3
Blank MRM of 4 channels.AP+
x73>1592
11 248 6 587e+003
10 565
81
yo

mtn

Blank MRM of 4 channels,AP+

367 3 > 145..1
2 47 I342e+003

vo 459 75 2 80
mrn
2.00 400 600 800

I RT Area 1 to Ratio (A.

1 Provrtamine D3 00

Analysed By q-a Checked By: J ,r"l \

t \k

o2(rr(2o2:_
AURIGA RESEARCH PRIVATE LIMITED
Quantify Sample Report MassLynx V4.2 SCN1001
Dataset: D:\ARBLEQLCMS-002\2022\NOV_2022\Developmentvitamine.PRO\PeakDB\l7112022_Vitamine.qld
Last Altered: Monday, November 07,2022 09t18:14 lndia Standard Time

Name: 05112022_Vitam ine_10, Oate: 05-Nov-2022, Time: 19:00:25, lO: Matrix-Blank, Oescription: , Vial: 1 :A,3

Provitamine D3
Matrix_Blank MRM of 4 channels,AP+
367.3 > 159.2
247 3.617e+004
198 2.66
o/o 3t.zz
min

Matrix_Blank MRM of 4 channels,AP+

367 3 > 145 1
2.47 6 242e+OO4
197
-1 min
2.00 400 600 800

1 1 Provrtamrne D3 4 58 2462666 2496.017 0.987 0.0 26

\\ \v*,--'
Analysed By: Checked By: o

ox lr'\ttz z-
 AURIGA RESEARCH PRIVATE LIMITED
Quantify Sample Report MassLynx V4.2 SCNloOl
Dataset: D:\ARBLEQ tCMS-002\2022\NOV_2022\Developm ent\Vitam ine. PRO\Peak DB\071 12022_Vitam ine.qtd
Last Altered: Monday, November07,2022 09:18:14 lndta Standard Time

Name: 05112022-Vitamine-11, Date: 05-Nov-2022, Timei 19:1'l:32,|D: Matrix_Blank, Description: , Vial: 1:A,4

Provitamine D3
Matnx_Blank MRM of 4 channels,AP+
367 3 > .159 2
4.424e+0O4
o/o
5
0 91 21
-1 mtn

Matrix Blank MRM of 4 channels,AP+

367.3 > 145 1
247 5 280e+004
198
572
-1 mln
200 4.00 600 8.00

1o Ratro
1 1 Provrtamrne D3 4 58 4782 755 4618.668 1036 00 51 1

Analysed By q--1 Checked By

o
ll \k
b,+lrr\Qa2L
AURIGA RESEARCH PRIVATE LIMITED
Quantify Sample Report MassLynx V4.2 SCN1001
Dataset: D:\ARBLEQLCMS-002\2022\NOV_2022\Developmentvitamine. PRO\PeakDB\071 12022_Vitam ine. qld
Last Altered: Monday, Novem ber 07 , 2022 09: 18; 14 lndia Standard Tim e

Name: 05112022_Vitamine_12, Date: 05-Nov-2022,'f imei 19:22i38, |D: Matrix_Blank, Description: , Vial: 1 :A,5

Provitamine D3
Matnx_Blank MRM of 4 channels,AP+
367 3 > '!59 2
2 46 3.315e+004
197 264
-1 mtn

Matnx_Blank MRM of 4 channels.AP+

3673 > 145 1
2.47 5 580e+004

ok 196
mrn
2.00 400 600 800

RT
I Provrtamine D3 4.58 3112.228 3346.0't 9 0.930 0.0 33.

Analysed By:
$1,,1,o"
Checked By
o x\ \r \t,1------
AURIGA RESEARCH PRIVATE LIMITED
Quantify Sample Report MassLynx V4.2 SCN1001
Dataset: D:\ARBLEQLCMS-002\2022\NOV_2022\Development\Vitamine.PRO\PeakDB\071 12022_Vitamine.qtd
Last Altered: Monday, November07,2022 09:18:14 lndia Standard Time

Name: 05112022_Vitam ine_13, Oate: 05-Nov-2022,Time: 19:33:43, lD: Matrix_Spike, Description: , Viat: 1:A,6

Provitamine D3
Matrix_Spike MRM of 4 channets,AP+
367 3 > 159.2
1030e+005
o/o 247
572
-1 mrn

Matrix_Spike MRM ot4 channels,AP+

3673> 145 1
9 704e+004
246
va
0 91
mrn
200 400 600 800

1 Provrtamine D3 4.58 11525762',t1209.260 1028 00 123 1

Analysed By:
M o? (rr \ L"LL
Checked By: (J \r
AURIGA RESEARCH PRIVATE LIMITED
Quantify Sample Report MassLynx v4.2 SCN1001
Dataset: D:\ARBLEQLCMS-002\2022\NOV_2022\Developmentvitamine. PRO\PeakDB\071 '12022-Vitam ine.qld
Last Altered: Monday, November 07,2022 09:18:'14 lndia Standard Time

Name: 05112022_Vitamine-14, Date: 05-Nov-2022,Iime:. 19:44i49,|D: Matrix_Spike, Description: , Vial: 1:A,7

Provitamine 03
Matrix_Spike MRM of 4 channels,AP+
3673>1592
1099e+005
90-:
Y.1 246
5 71
-1 mtn

Matnx_Spike MRM of 4 channels,AP+

367.3 > 145.'l
1078e+005
246
-l mrn
200 400 600 8.00

1 1 Provitamine D3 4 57 12041 146 12351 982 0975 00 128.6

\ t.---
Analysed By Checked By.
t-
c?l\\ \2 02
AURIGA RESEARCH PRIVATE LIMITED
Quantify Sample Report MassLynx V4.2 SCN1001
Dataset: D:\ARBLEQLCM5-002\2022\NOV_2022\Development\Vitamine.PRO\PeakDB\071 12022_Vitam ine. qld
Last Altered: IVlonday, November 07,2022 09;18:14 lndia Standard Time

Name: 05112022_Vitamine_15, Date: 05-Nov-2022, Time: 19:55:54, lD: Matrix_Spike, Description: , Viat: 1:A,8

Provitamine D3
Matrix_Sprke MRM of 4 channels AP+
367 3 > 159.2
1048e+005

Yo 247
72
-1 mtn

Matrix_Spike MRM of4 channels,AP+

367 3 > .145 1

I842er004
247

-1 mrn
2 00 4.00 6.00 I00

1 1 Provrtamine D3 4 58 11184 577 10622 375 1.053 0.0 119

Analysed By: Checked By o

ll \ L..--
oa l1r\oo 12-
AURIGA RESEARCH PRIVATE LIMITED
Quantify Sample Report MassLynx V4.2 SCN1001
Dataset: D:\ARBLEQLCMS-002\2022\NOV_2022\Development\Vitam ine. PRO\PeakDB\071 12022_Vitam ine.qld
Last Allered: Monday, November 07, 2022 09:18.14 lndia Standard Time

Name:051'12022_Vitamine_16, Date: 05-Nov-2022,Timei 20:07:00, lD: Blank-Spike, Description:, Vial:1:B,'l

Provitamine D3
Blank_Spike MRM of 4 channels.AP+
3673>1592
I 354e+004

246
mtn

Blank_Spike MRM of 4 channels,AP+

3673>1451
8.808e+004
247
mtn
2 0 400 600 800

RI 1 Conc
1 1 Provitamine D3 4 58 10567.615 9937 508 1 063 0.0 112.

(
\'^--
Analysed By q-1 Checked By:
o
\r \ )

hlulooc-'
AURIGA RESEARCH PRIVATE LIMITED
Quantify Sample Report MassLynx V4.2 SCN1001
Datasel: D:\ARBLEQLCM5-002\2022\NOV_2022\Development\Vitamine.PRO\PeakDB\071 12022_Vitamine. qtd
Last Altered: Monday, Novembe.07,2022 09:18:14 lndia Standard Time

Name: 05112022-Vitam ine_17, Oate: 05-Nov-2022, Time:20:18:06, lD: Blank_Spike, Description: , Vial: 1:8,2

Provitamine D3
Blank_Spike MRM of 4 channels,AP+
3673>1592
I737e+004

vo 247
-1 mrn

Blank_Spike MRM ol4 channels,AP+

367 3 > 145 I
8 914e+004
247
-1 min
200 400 600 800

1 'l Provitamrne 03 4.58 10704 192 101 18 908 't.058 0 0 114.

L--
Analysed By: Checked By \r \
@--1
iafultot t
 AURIGA RESEARCH PRIVATE LIMITED
Quantify Sample Report MassLynx V4.2 SCN1001
Datasetr D:\ARBLEQLCMS-002\2022\NOV_2022\Development\Vitamine PRO\PeakDB\07112022_Vitamine.qld
Last Altered: Monday, November 07, 2022 09.18:14 lndia Standard Time

Name: 051 12022_Vitamine_18, Date: 05-Nov-2022, Timel 20:29:'l'1,lD: Blank_Spike, Description:, Vial: 1:B,3

Provitamine D3
Blank_Spike MRM of 4 channels,AP+
367.3 > 159 2
I 222e+OO4

247
mtn

Blank_Spike MRM of 4 channels,AP+

367 3 > 145 1
9.086e+004
247
-10 min
200 4.00 600 800

RT
1 '1 Provitamine D3 4.59 10917.585 10277.556 1 062 0.0 1 16.

t
Analysed By: Checked 8y: \r \
%t,, toL t^ I
o
AURIGA RESEARCH PRIVATE LIMITED
Quantify Sample Report MassLynx V4.2 SCN'!001
Dataset: D:\ARBLEQLCMS-002\2022\NOV 2022\Development\Vitam ine. PRO\PeakDB\071 12022-Vitam ine.qld
Last Altered: Monday, Novembet 07.2022 09:18:14 lndia Standard Time

Name: 05112022-Vitamine-19, Date: O5'Nov'2022, Time: 2Ot4O:17,1O: Blank, Description: , Vial: 1:A'1

Provitamine 03
Blank MRM of 4 channels,AP+
3673>1592
246 6 110e+003
2 615 7 a2 70

min

Blank MRM of 4 channels.AP+

367 3> 145 1
2.48 7.034e+003
088 4.60 7 56 9.20 74

-1 mtn
200 400 600 800
RT Area 1o Ar€a Factorl
1 1 Provitamrne D3 00

Analysed 8y: Checked By: <)

lr \r
%-1
o?[rt (a r', L
AURIGA RESEARCH PRIVATE LIMITED
Quantify Sample Report MassLynx V4.2 SCN1001
Dataset: D:\ARBLEQLCMS-002\2022\NOV_2022\Developmentvitamine. PRO\PeakDB\071 12022_Vitam ine.qld
Last Altered: Monday, November 07, 2022 09.18:14 lndia Standard Time

Name: 05112022_Vitamine_20, Date: 05-Nov-2022, Time: 20:51:23,1O: System Suitibility Solution_01, Description: , Vial: 'l:A,2

Provitamine D3
MRi, of 4 channels,AP+
367 3 > 159.2
9 329e+004
90:
Y"1
247
-1 min

MRM of 4 channels,AP+
367 .3 > 145.1
8 759e+004

o/a
247
-1 mrn
2.00 4 00 6.00 8 00

Factorl
1 1 Provitamine D3 4 59 10559.540 10033.437 1 052 0 0 112.

\,\
Analysed By
@'1 Checked By:

hlicott-
AURIGA RESEARCH PRIVATE LITVIITED
Quantify Sample Report MassLynx V4.2 SCN1001
Dataset: D:\ARBLEQLCMS-002\2022\NOV_2022\Development\Vitamine.PRO\PeakDB\071 12022_Vitam ine.qld
Last Altered: Monday, Novembet 07,2022 09:'18:14 India Standard Time

Name: 05112022_Vitam ine_21, Date: 05-Nov-2022,Timei 21:02:28,|D: Blank, Description: , Vial: 1 :A,1

Provitamine D3
Blank MRM of 4 channels,AP+
3673>1592
2.46 5.679e+003
9
o/.
089 41 60 8.63 21

Blank MRM of 4 channels,AP+

367 3 > 145.1
247 7.149e+003
90
o/o 090 6 82 9.32
10 mtn
2.00 4 00 6.00 I00

# Name RT Area 10 Area 10 Ratio (A. Factor,l Conc.

1 1 Provitamrne D3 00

Analysed By Checked By: r \ \-t---

lrr (trI L